Marcel Imwinkelried, Chief Executive Officer Siegfried: “Aligned with Siegfried's strategy EVOLVE+, the new lab facility marks a key milestone in DINAMIQS' journey to becoming the leading CDMO in the ...

Second, our clinical ... science that established dd-cfDNA as a trusted biomarker 4, and we are now commercializing a product by pursuing a market disruptive approach. We aim to deliver proven, more ...

Through brain implants, neural interfaces and skin grafts, researchers are starting to restore sensation for paralysed or ...

One of the highlights of my career has always been connecting with customers and partners across industries to learn how they are using technology to drive their businesses forward. In the past 30 ...

University of B.C. researchers have developed a groundbreaking coating that could make medical devices safer for millions of patients, reducing the risks associated with blood clots and dangerous ...

Many functional proteins are like a key looking for a lock, and Google DeepMind's AlphaFold models can find that structure ...

The left image shows the immune organ-on-chip, where the organoids (right) are grown to study the response of human donors. The right image shows development of types of immune cells relevant to the ...